Edison、NJにおける乳がんの臨床試験
Edisonとその周辺地域（約30マイル以内）の拠点で、乳がんに関する68件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
被験者募集中第2相
- Astera Cancer Care (Formerly Regional Cancer Care Associates), East Brunswick · 6マイル先
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Cancer
被験者募集中
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · 15マイル先
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
被験者募集中第1相
- Research Site, New Brunswick · 3マイル先
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
被験者募集中第3相
- Rutgers Cancer Institute of New Jersey ( Site 0033), New Brunswick · 3マイル先
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
被験者募集中
- Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township · 5マイル先
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
被験者募集中第3相
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick · 3マイル先
A Study of Language Interpretation Solutions for People With Breast Cancer
被験者募集中
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · 15マイル先
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
被験者募集中第1相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
被験者募集中
- Rutgers, New Brunswick · 3マイル先
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
被験者募集中第3相
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), New Brunswick · 3マイル先
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Somerville · 11マイル先
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge · 15マイル先
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
被験者募集中第3相
- Rutgers Cancer Institute, New Brunswick · 3マイル先
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
被験者募集中第1相
- START - New Jersey, East Brunswick · 6マイル先
A Phase 1/1b Study of IAM1363 in HER2 Cancers
被験者募集中第1相
- Rutgers Cancer Institute, New Brunswick · 3マイル先
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
被験者募集中第1/2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
被験者募集中第2相
- Astera Cancer Care East Brunswick, East Brunswick · 6マイル先
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
被験者募集中第3相
- Rutgers Cancer Institute, New Brunswick · 3マイル先
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
被験者募集中第3相
- Astera Cancer Care East Brunswick, East Brunswick · 6マイル先
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors
被験者募集中観察研究
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer
被験者募集中第2相
- Cooper Hospital University Medical Center, Voorhees Township · 5マイル先
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
被験者募集中
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
被験者募集中第3相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- MD Anderson Cancer Center at Cooper-Voorhees, Voorhees Township · 5マイル先
- Virtua Voorhees, Voorhees Township · 5マイル先
- 他1件
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
被験者募集中第1相
- START New Jersey, LLC, East Brunswick · 6マイル先
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
被験者募集中第1相
- Rutgers Cancer Institute, New Brunswick · 3マイル先
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick · 3マイル先
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term Remission
被験者募集中第2相
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Romosozumab in People With Breast Cancer and Osteoporosis
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
被験者募集中第3相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study of a Side Effects and Resource Navigation Program for People With Cancer
被験者募集中
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
被験者募集中
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15マイル先
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
被験者募集中第4相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery
被験者募集中
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
被験者募集中第3相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
被験者募集中
- Memorial Sloan Kettering Basking Ridge (Consent and Follow-up), Basking Ridge · 15マイル先
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
被験者募集中第1相
- Memorial Sloan Kettering at Basking Ridge (All protocol activities), Basking Ridge · 15マイル先
Rutgers University Study of the Genetics of Breast Cancer.
被験者募集中観察研究健康なボランティア歓迎
- Rutgers University, Piscataway · 2マイル先
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
被験者募集中第1/2相
- Rutgers Cancer Institute of New Jersey ( Site 0052), New Brunswick · 3マイル先
A Study of Blood Pressure Control During Cancer Treatment
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Surgery and Radiotherapy in People With Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Lymphedema Surveillance Study
被験者募集中観察研究
- Memorial Sloan Kettering Basking Ridge (Consent only), Basking Ridge · 15マイル先
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
被験者募集中第3相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Factors Associated With Breast Cancer Risks and Outcomes
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma
被験者募集中観察研究
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
被験者募集中第1/2相
- START, Astera, East Brunswick · 6マイル先
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
被験者募集中第2相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
被験者募集中第1相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
A Study of Revaree Plus in People With Breast Cancer
被験者募集中第4相
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · 15マイル先
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
被験者募集中
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- RWJBarnabas Health, New Brunswick · 3マイル先
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
被験者募集中観察研究
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
被験者募集中第4相
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick · 3マイル先
- RWJBarnabas Health - Robert Wood Johnson University Hospital, Somerset · 4マイル先
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
被験者募集中第1相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
- RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset, Somerville · 11マイル先
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
被験者募集中第4相
- Jack and Sheryl Morris Cancer Center, New Brunswick · 3マイル先
- RWJBarnabas Health - Robert Wood Johnson University Hospita, New Brunswick · 3マイル先
- RWJBarnabas Health - Robert Wood Johnson University Hospital Somerset, Somerville · 11マイル先
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
被験者募集中第3相
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15マイル先
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New Brunswick · 3マイル先
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15マイル先
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
被験者募集中第1相
- Rutgers University, New Brunswick · 3マイル先
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #9, New Brunswick · 3マイル先
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
被験者募集中第2相
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3マイル先
他の都市における乳がんの試験
- New York City, NY134件の研究
- Houston, TX126件の研究
- Boston, MA111件の研究
- Nashville, TN80件の研究
- Los Angeles, CA72件の研究
- St. Louis, MO64件の研究
- Durham, NC63件の研究
- Queens, NY63件の研究
- Chicago, IL58件の研究
- Philadelphia, PA56件の研究
- Dallas, TX55件の研究
- Baltimore, MD47件の研究
Edisonにおける他の研究
- 非小細胞肺癌47件の研究
- がん（全種類）33件の研究
- 前立腺がん29件の研究
- 大腸癌23件の研究
- 肺がん23件の研究
- 多発性骨髄腫22件の研究
- 膀胱癌21件の研究
- 転移性癌20件の研究
- 卵巣がん20件の研究
- 急性骨髄性白血病20件の研究
- 子宮内膜がん19件の研究
- 尿路上皮（移行上皮）癌18件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。